Refreshing results…
Trajectories of the SARS‐CoV ‐2 RNA load in patients with hematological malignancy
UploadAdult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
UploadMissing publications? Search for publications with a matching author name.